Go Back to Match Results for "trials"
Prospective Randomized Open Label Multi-center Study of the Safety and Pharmacokinetics of Apixaban versus Vitamin K Antagonist or Low Molecular Weight Heparin in Pediatric Subjects with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention
Study Overview
The purpose of this study is to find out whether apixaban is safe for children to take, and how much apixaban will be in their blood when they take a certain apixaban dose. We will compare apixaban to other blood thinners commonly used.
Study Description
The purpose of this study is to find out whether apixaban is safe for children to take, and how much apixaban will be in their blood when they take a certain apixaban dose. We will compare apixaban to other blood thinners commonly used.
Additional Information
- IRB Number: 1610988844
- Research Study Identifier: TX7573
- Principal Investigator: R. Mark Payne, MD
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required
